Anti-Candida Albicans HSP91 Homolog Recombinant Antibody
-
产品编号
YR1109
-
别名
科研级 Efungumab ( 依芬古单抗 ), Anti-HSP91 Homolog Recombinant Antibody, Research Grade Efungumab
-
规格
- 1mg
- 5mg
产品介绍
| Alias | 科研级 Efungumab ( 依芬古单抗 ), Anti-HSP91 Homolog Recombinant Antibody, Research Grade Efungumab |
| Catalog Number | YR1109 |
| Molecular Name | Efungumab |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | scFv-heavy Kappa |
| Formulation | PBS, pH7.5 |
| Background | Efungumab (trade name Mycograb) was a drug developed by NeuTec Pharma (a subsidiary of Novartis), intended to treat candidemia (a bloodstream infection caused by pathogenic yeast) in combination with amphotericin B. The European Medicines Agency has twice refused to grant marketing authorization for Mycograb, citing product safety and quality issues. |
| CAS Number | 762260-74-2 |
| Application | FCM, IP, ELISA, Neut, FuncS, IF, WB |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Target | HSP91 homolog[Candida albicans] |
- 联系我们
- 电话：400-621-6806
- 手机：13116038708
- 邮箱：info@kmdbioscience.com
- 地址：天津市武清区国际企业社区A5号楼
-
销售微信
-
官方公众号
-
400-621-6806 -
614353794 -
周一至周五 9:00-18:00 -
-
0
-
